Back
ESC Premium Access

Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry

Session: Oral anticoagulants : news from large trials and registries
Topic: Anticoagulants
Speaker: Associate Professor M. Proietti (Milan, IT)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Associate Professor Marco Proietti

University of Milan, Milan (Italy)
11 presentations
0 follower

5 more presentations in this session

Real-world clinical data of atrial fibrillation patients treated with direct oral anticoagulants in combination with or without antiplatelet therapy

Speaker: Doctor R. Amiya (Osaka, JP)

Access
Abstract
Slides
Thumbnail

Characterization of major and clinically relevant non-major bleeding in the APEX trial

Speaker: Miss M. Yee (Boston, US)

Access
Abstract
Slides
Thumbnail

Increased major bleeding risk with use of topical miconazole agents among users of oral anticoagulation: A population-level safety study

Speaker: Doctor M. Lamberts (Copenhagen, DK)

Access
Abstract
Slides
Thumbnail

Comparison of P2Y12 inhibitors in atrial fibrillation patients treated by dual-antiplatelet therapy without oral anticoagulant after acute myocardial infarction with percutaneous coronary intervention

Speaker: Professor H. Jeong (Iksan, KR)

Access
Abstract
Slides
Thumbnail

Oral anticoagulants in patients with atrial fibrillation and non-mechanical heart valve disease

Speaker: Mr J. Strange (Copenhagen, DK)

Access
Abstract
Slides
Thumbnail

Access the full session

Oral anticoagulants : news from large trials and registries

Speakers: Associate Professor M. Proietti, Doctor R. Amiya, Miss M. Yee, Doctor M. Lamberts, Professor H. Jeong...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb